Cargando…

Temsirolimus in Asian Metastatic/Recurrent Non-clear Cell Renal Carcinoma

PURPOSE: Temsirolimus is effective in the treatment for metastatic non-clear cell renal cell carcinoma (nccRCC) with poor prognosis. We aim to investigate the efficacy and tolerability of temsirolimus in treatment of naïve Asian patients with metastatic/recurrent nccRCC. MATERIALS AND METHODS: From...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Jii Bum, Park, Hyung Soon, Park, Sejung, Lee, Hyo Jin, Kwon, Kyung A, Choi, Young Jin, Kim, Yu Jung, Nam, Chung Mo, Cho, Nam Hoon, Kang, Beodeul, Chung, Hyun Cheol, Rha, Sun Young
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Cancer Association 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790860/ https://www.ncbi.nlm.nih.gov/pubmed/30999721 http://dx.doi.org/10.4143/crt.2018.671

Ejemplares similares

Comprehensive immune profiling and immune-monitoring using body fluid of patients with metastatic gastric cancer
por: Park, Hyung Soon, et al.
Publicado: (2019)

Detection of asymptomatic recurrence improves survival of gastric cancer patients
por: Park, Ji Soo, et al.
Publicado: (2021)

Comparison of three risk stratification models for non-clear cell renal cell carcinoma patients treated with temsirolimus as first-line therapy
por: Lee, In Hee, et al.
Publicado: (2020)

Metastatic clear cell renal carcinoma – an unusual response to Temsirolimus in second line therapy
por: Stanculeanu, DL, et al.
Publicado: (2016)

A single arm phase Ib/II trial of first-line pembrolizumab, trastuzumab and chemotherapy for advanced HER2-positive gastric cancer
por: Lee, Choong-kun, et al.
Publicado: (2022)

Long-term response of metastatic hereditary leiomyomatosis and renal cell carcinoma syndrome associated renal cell carcinoma to bevacizumab plus erlotinib after temsirolimus and axitinib treatment failures
por: Park, Inkeun, et al.
Publicado: (2019)

Efficacy of temsirolimus in metastatic chromophobe renal cell carcinoma
por: Venugopal, Balaji, et al.
Publicado: (2013)

Differential effects of ketoconazole on exposure to temsirolimus following intravenous infusion of temsirolimus
por: Boni, J P, et al.
Publicado: (2008)

Histologic Variations and Immunohistochemical Features of Metastatic Clear Cell Renal Cell Carcinoma
por: Lee, Cheol, et al.
Publicado: (2013)

Visceral Adiposity as a Significant Predictor of Sunitinib-Induced Dose-Limiting Toxicities and Survival in Patients with Metastatic Clear Cell Renal Cell Carcinoma
por: Park, Jee Soo, et al.
Publicado: (2020)

Phase 2 study of TAS-117, an allosteric akt inhibitor in advanced solid tumors harboring phosphatidylinositol 3-kinase/v-akt murine thymoma viral oncogene homolog gene mutations
por: Lee, Jii Bum, et al.
Publicado: (2021)

A Phase I Study of the Combination of Temsirolimus with Irinotecan for Metastatic Sarcoma
por: Verschraegen, Claire F., et al.
Publicado: (2013)

‘Screening audit’ as a quality assurance tool in good clinical practice compliant research environments
por: Park, Sinyoung, et al.
Publicado: (2018)

Temsirolimus for patients with metastatic renal cell carcinoma: outcomes in patients receiving temsirolimus within a compassionate use program in a tertiary referral center
por: Afshar, Mehran, et al.
Publicado: (2014)

Impact of Market Competition on Continuity of Care and Hospital Admissions for Asthmatic Children: A Longitudinal Analysis of Nationwide Health Insurance Data 2009-2013
por: Cho, Kyoung Hee, et al.
Publicado: (2016)

Evaluation of Assisted Reproductive Technology Health Insurance Coverage for Multiple Pregnancies and Births in Korea
por: Cha, Wontae, et al.
Publicado: (2023)

The impact of assisted reproductive technology treatment coverage on marriage, pregnancy, and childbirth in women of childbearing age: an interrupted time-series analysis
por: Yun, Il, et al.
Publicado: (2023)

Health behavior changes and mortality among South Korean cancer survivors
por: Jeong, Wonjeong, et al.
Publicado: (2022)

Significance of Metabolic Tumor Volume and Total Lesion Glycolysis Measured Using (18)F-FDG PET/CT in Locally Advanced and Metastatic Gallbladder Carcinoma
por: Chun, You Jin, et al.
Publicado: (2019)

Evaluating the activity of temsirolimus in neuroendocrine cancer
por: O'Donnell, P H, et al.
Publicado: (2007)

Temsirolimus in overtreated metastatic renal cancer with subsequent use of sunitinib: A case report
por: JURADO, JOSÉ MIGUEL, et al.
Publicado: (2013)

Breakthroughs in the Systemic Treatment of HER2-Positive Advanced/Metastatic Gastric Cancer: From Singlet Chemotherapy to Triple Combination
por: Rha, Sun Young, et al.
Publicado: (2023)

Real-World Clinical Data of Palbociclib in Asian Metastatic Breast Cancer Patients: Experiences from Eight Institutions
por: Lee, Jieun, et al.
Publicado: (2021)

Gene Expression Analysis of Aggressive Clinical T1 Stage Clear Cell Renal Cell Carcinoma for Identifying Potential Diagnostic and Prognostic Biomarkers
por: Park, Jee Soo, et al.
Publicado: (2020)

Bone alkaline phosphatase as a surrogate marker of bone metastasis in gastric cancer patients
por: Lim, Sun Min, et al.
Publicado: (2016)

Guidelines for Cancer Care during the COVID-19 Pandemic in South Korea
por: Lee, Jii Bum, et al.
Publicado: (2021)

Prediction of metachronous multiple primary cancers following the curative resection of gastric cancer
por: Kim, Chan, et al.
Publicado: (2013)

Longer recurrence‐free survival in a patient with metastatic renal cell carcinoma treated with temsirolimus
por: Satoh, Tendo, et al.
Publicado: (2017)

Reply: Evaluating the activity of temsirolimus in neuroendocrine cancer
por: Duran, I, et al.
Publicado: (2007)

Addition of Bevacizumab to Temsirolimus in Kidney Cancer Patients
por: Boyle, H., et al.
Publicado: (2011)

A pilot study of temsirolimus and body composition
por: Veasey-Rodrigues, Heloisa, et al.
Publicado: (2013)

Cardiotoxicity of trastuzumab in patients with HER2-positive gastric cancer
por: Soo Park, Ji, et al.
Publicado: (2017)

Development of the clinical calculator for mortality of patients with metastatic clear cell type renal cell carcinoma: An analysis of patients from Korean Renal Cancer Study Group database
por: Park, Jae Young, et al.
Publicado: (2020)

A phase II study of alternating sunitinib and temsirolimus therapy in patients with metastatic renal cell carcinoma
por: Ness, Dylan B., et al.
Publicado: (2023)

Efficacy and Toxicity of Mammalian Target Rapamycin Inhibitors in Patients with Metastatic Renal Cell Carcinoma with Renal Insufficiency: The Korean Cancer Study Group GU 14-08
por: Kim, Ki Hyang, et al.
Publicado: (2016)

Ferroportin and FBXL5 as Prognostic Markers in Advanced Stage Clear Cell Renal Cell Carcinoma
por: Park, Cheol Keun, et al.
Publicado: (2021)

Hepatic resection of metastatic tumor from serous cystadenocarcinoma of the ovary.
por: Lee, Jong Hoon, et al.
Publicado: (2002)

Detection of sexually transmitted infection and human papillomavirus in negative cytology by multiplex-PCR
por: Shim, Hyo-Sub, et al.
Publicado: (2010)

Salvage chemotherapy of biweekly irinotecan plus S-1 (biweekly IRIS) in previously treated patients with advanced gastric cancer
por: Chon, Hong Jae, et al.
Publicado: (2011)

Complete mitochondrial genome of Asian koel Eudynamys scolopaceus (Aves: Cuculiformes) from South Korea
por: Lee, Yun Sun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ea0lprrs60fihoafat9e33i7qv